{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:26:51Z","timestamp":1783132011661,"version":"3.54.6"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.pnpbp.2009.11.012","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T15:27:35Z","timestamp":1258730855000},"page":"225-230","source":"Crossref","is-referenced-by-count":22,"title":["Clinician-rated functioning and patient-rated quality of life in schizophrenia: Implications of their correspondence for psychopathology and side effects"],"prefix":"10.1016","volume":"34","author":[{"given":"Hee Yeon","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Suk-Hyun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Seo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeni","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2009.11.012_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1570159052773440","article-title":"Gender differences in pharmacokinetics and side effects of second generation antipsychotic drugs","volume":"3","author":"Aichhorn","year":"2005","journal-title":"Curr Neuropharm"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.psychres.2006.05.017","article-title":"Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia","volume":"158","author":"Aki","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib3","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC; 2000 [text rev.]."},{"issue":"a","key":"10.1016\/j.pnpbp.2009.11.012_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0327(97)00041-4","article-title":"The differential effects of mood on patients' ratings of life quality and satisfaction with their care","volume":"44","author":"Atkinson","year":"1997","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1176\/ajp.154.1.99","article-title":"Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology","volume":"154","author":"Atkinson","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1026409326690","article-title":"A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation","volume":"6","author":"Awad","year":"1997","journal-title":"Qual Life Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0447.2008.01310.x","article-title":"Side-effects of antipsychotic medication and health-related quality of life in schizophrenia","author":"Bebbington","year":"2009","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00406-003-0436-3","article-title":"Determinants of subjective quality of life in post acute patients with schizophrenia","volume":"253","author":"Bechdolf","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jpsychires.2006.08.003","article-title":"Self-assessment of functional status in schizophrenia","volume":"41","author":"Bowie","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0447.1996.tb09835.x","article-title":"Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia","volume":"94","author":"Browne","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1176\/appi.ps.56.4.444","article-title":"Selection of outcome assessment instruments for inpatients with severe and persistent mental illness","volume":"56","author":"Burlingame","year":"2005","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0447.1997.tb10157.x","article-title":"Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients","volume":"96","author":"Carpiniello","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0447.1998.tb09969.x","article-title":"A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: prevalence, distress and causation","volume":"97","author":"Day","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0924-9338(01)00609-5","article-title":"Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics","volume":"16","author":"Dernovsek","year":"2001","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib15","series-title":"SCL-90(Revised) Manual I","author":"Derogatis","year":"1977"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.128.3.280","article-title":"The SCL-90 and the MMPI: a step in the validation of a new self-report scale","volume":"128","author":"Derogatis","year":"1976","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0447.1998.tb10053.x","article-title":"Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates","volume":"98","author":"Dickerson","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/schbul\/sbl071","article-title":"Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis","volume":"33","author":"Eack","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2975\/30.3.2007.219.222","article-title":"Quality of life for persons living with schizophrenia: more than just symptoms","volume":"30","author":"Eack","year":"2007","journal-title":"Psychiatr Rehabil J"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1034\/j.1600-0447.2001.00254.x","article-title":"Subject and observer-rated quality of life in schizophrenia","volume":"103","author":"Fitzgerald","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0920-9964(96)85732-X","article-title":"An inventory of chronic, mentally disabled schizophrenic outpatients","volume":"18","author":"Flyckt","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib22","doi-asserted-by":"crossref","first-page":"s64","DOI":"10.1192\/bjp.191.50.s64","article-title":"Adverse effects of antipsychotics as outcome measures","volume":"50","author":"Hamer","year":"2007","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.schres.2007.03.005","article-title":"A prospective study of quality of life in schizophrenia in three European countries","volume":"93","author":"Heider","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(99)00151-6","article-title":"Quality of life in schizophrenia: contributions of anxiety and depression","volume":"51","author":"Huppert","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(96)02958-7","article-title":"Profiles of subjective quality of life in schizophrenic in- and out-patient samples","volume":"66","author":"Kaiser","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1052-z","article-title":"Subjective well-being and quality of life under atypical antipsychotic treatment","volume":"162","author":"Karow","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00406-007-0768-5","article-title":"The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life","volume":"258","author":"Karow","year":"2008","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-1781(01)00260-8","article-title":"Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients","volume":"103","author":"Kasckow","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib29","first-page":"278","article-title":"The standardization study of Symptom Checklist-90-Revision in Korea III","volume":"2","author":"Kim","year":"1984","journal-title":"Mental Health Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib30","first-page":"166","article-title":"Reliability and factorial invariance of Korean version of the Symptom Checklist-90-Reivision","volume":"3","author":"Kim","year":"1985","journal-title":"Mental Health Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardized psychiatric assessment scale for rating chronic psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.psychres.2005.06.012","article-title":"Quality of life for patients with schizophrenia in a Japanese psychiatric hospital","volume":"144","author":"Kugo","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000064809","article-title":"Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology \u2014 the South-Verona Outcome Project 6","volume":"71","author":"Lasalvia","year":"2002","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0447.1996.tb10664.x","article-title":"Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics","volume":"93","author":"Larsen","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1983.01790040023003","article-title":"The well-being of chronic mental patients: assessing their quality of life","volume":"40","author":"Lehman","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.0065-1591.2000.0ap25.x","article-title":"Sex differences in schizophrenia, a review of the literature","volume":"101","author":"Leung","year":"2003","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.pnpbp.2009.11.012_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/schbul\/sbm002","article-title":"Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review","volume":"33","author":"Lincoln","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2005.12.844","article-title":"Associations of symptoms, psychosocial function and hope with qualities of self-experience in schizophrenia: comparisons of objective and subjective indicators of health","volume":"82","author":"Lysaker","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-0447.1986.tb06285.x","article-title":"Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms","volume":"74","author":"Manchanda","year":"1986","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0277-9536(94)90324-7","article-title":"Effects of illness attribution and depression on the quality of life among persons with serious mental illness","volume":"39","author":"Mechanic","year":"1994","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.eurpsy.2005.03.002","article-title":"Measuring quality of life in first-episode psychosis","volume":"20","author":"Melle","year":"2005","journal-title":"Eur Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.pnpbp.2009.11.012_bib42","first-page":"133","article-title":"A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables","volume":"10","author":"Naber","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0920-9964(00)00166-3","article-title":"Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs","volume":"50","author":"Naber","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0447.2004.00486.x","article-title":"Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia","volume":"111","author":"Naber","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2007.09.001","article-title":"Subjective and objective quality of life in schizophrenia","volume":"98","author":"Narvaez","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib46","first-page":"22","article-title":"Age\u2013intelligence relationship in adulthood: a cross sectional analysis of K-WAIS standardization data","volume":"11","author":"Oh","year":"1992","journal-title":"Korean J Clin Psychology"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eurpsy.2008.05.001","article-title":"Axis V \u2013 Global Assessment of Functioning Scale (GAF), further evaluation of the self-report version","volume":"23","author":"Ramirez","year":"2008","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1192\/bjp.178.3.268","article-title":"Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: the South Verona Outcome Project 4","volume":"178","author":"Ruggeri","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib48","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1176\/appi.ps.56.4.434","article-title":"Special section on the GAF: reliability of Global Assessment of Functioning ratings made by clinical psychiatric staff","volume":"56","author":"S\u00f6derberg","year":"2005","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1348\/014466502760387533","article-title":"The concurrent validity of the Global Assessment of Functioning (GAF)","volume":"41","author":"Startup","year":"2002","journal-title":"Br J Clin Psychol"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psychres.2004.10.009","article-title":"Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics","volume":"133","author":"Strejilevich","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/gps.711","article-title":"Development and evaluation of a health-related quality of life questionnaire for the elderly with dementia in Japan","volume":"17","author":"Terada","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0033291797005874","article-title":"Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability","volume":"28","author":"Voruganti","year":"1998","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0920-9964(99)00154-1","article-title":"Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life","volume":"43","author":"Voruganti","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.schbul.a033349","article-title":"The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy","volume":"24","author":"Warner","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.pnpbp.2007.01.004","article-title":"Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia","volume":"31","author":"Wehmeier","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1440-1819.2008.01818.x","article-title":"Predictors of subjective and objective quality of life in outpatients with schizophrenia","volume":"62","author":"Yamauchi","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib57","first-page":"157","article-title":"Development of the Life Satisfaction Rating Scale","volume":"24","author":"Yang","year":"1994","journal-title":"Korean J. Social Welfare"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","article-title":"Gender differences in tardive dyskinesia: a critical review of the literature","volume":"18","author":"Yassa","year":"1992","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib59","first-page":"118","article-title":"Reliability and validity of the Korean Version of Global Assessment of Functioning Scale","volume":"6","author":"Yi","year":"2003","journal-title":"Schizophrenia Clinics"},{"key":"10.1016\/j.pnpbp.2009.11.012_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2003.11.005","article-title":"Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients","volume":"71","author":"Zhang","year":"2004","journal-title":"Schizophr Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609003984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609003984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T03:57:02Z","timestamp":1544846222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584609003984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0278584609003984"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.11.012","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}